brentuximab vedotin
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications:
Pronunciation:
bren-tux-i-mab
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Adcetris
Ther. Class.
Pharm. Class.
drug-antibody conjugates
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Brentuximab Vedotin." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2026. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/110908/5/brentuximab_vedotin.
Vallerand AHA, Sanoski CAC, . Brentuximab vedotin. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/110908/5/brentuximab_vedotin. Accessed March 12, 2026.
Vallerand, A. H., Sanoski, C. A., & , (2026). Brentuximab vedotin. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/110908/5/brentuximab_vedotin
Vallerand AHA, Sanoski CAC, . Brentuximab Vedotin [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 March 12]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/110908/5/brentuximab_vedotin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - brentuximab vedotin
ID - 110908
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/110908/5/brentuximab_vedotin
PB - F.A. Davis Company
ET - 19
DB - The Washington Manual
DP - Unbound Medicine
ER -

Davis's Drug Guide

